Ryan Haumschild, PharmD, MS, MBA, leads expert panelists in a conversation exploring the prevalence and clinical burden impact of MDS. Ryan Haumschild, PharmD, MS, MBA: As we start to look at benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results